[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:chronic-renal-failure":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":202,"states":207},"Chronic Renal Failure",31,20,[8,16,22,28,34,40,47,54,60,66,72,78,85,91,97,103,109,115,121,127,133,141,147,153,159,165,171,177,184,190,196],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06972069","Tolerance Through Mixed Chimerism (Sip-Tego)",[12],"Early Phase 1","RECRUITING","2026-08-26T02:19:06.150683Z","2026-07-24T01:27:14.896734Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT04634916","Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System",[],"2026-08-26T02:19:30.857183Z","2026-05-05T02:43:29.510215Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT04954690","Structured Program of Exercise for Recipients of Kidney Transplantation",[],"2026-08-26T02:16:59.895916Z","2026-05-05T02:43:28.346440Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT05465044","Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)",[],"2026-08-26T02:18:53.782384Z","2026-05-05T02:43:28.216482Z",{"nct_id":35,"title":36,"phases":37,"status":13,"updated_at":38,"content_modified":39},"NCT06647017","Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures",[],"2026-08-26T02:19:03.581490Z","2026-05-05T02:43:28.180366Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":45,"content_modified":46},"NCT07224763","Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD",[44],"Phase 1\u002FPhase 2","2026-08-26T02:14:59.425132Z","2026-05-05T02:43:28.114641Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":52,"content_modified":53},"NCT05339139","SAfety of Regional Citrate Anticoagulation (SARCA Study)",[51],"Phase 3","2026-08-26T02:15:38.131683Z","2026-05-05T02:43:28.015701Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT06830798","Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation",[51],"2026-08-26T02:15:11.740957Z","2026-05-05T02:43:27.662859Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT05814146","Trial of Variable Dialysate Bicarbonate",[],"2026-08-26T02:16:00.194860Z","2026-05-05T02:43:27.075956Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT05931276","CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes",[51],"2026-08-26T02:17:30.145302Z","2026-05-05T02:43:27.064570Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT05828823","Incremental Hemodialysis: The TwoPlus Trial",[],"2026-08-26T02:18:47.742071Z","2026-05-05T02:43:26.974512Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":83,"content_modified":84},"NCT07348237","A Clinical Trial of MK-2828 in People With Kidney Disease (MK-2828-006)",[82],"Phase 1","2026-08-26T02:15:48.613507Z","2026-05-05T02:43:26.962068Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT06878560","Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD",[44],"2026-08-26T02:16:50.548894Z","2026-05-05T02:35:31.909367Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT03480568","Alirocumab in Patients on a Stable Dialysis Regimen",[51],"2026-08-26T02:18:37.277498Z","2026-05-29T15:36:40.161495Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT06366230","Adding Urea to the Final Dialysis Fluid",[44],"2026-08-26T02:18:49.989941Z","2026-05-05T02:43:27.672840Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT06749457","A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)",[44],"2026-08-26T02:18:17.007929Z","2026-05-05T02:43:27.447143Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT07178470","Concordance and Discordance in the Assessment of Volume Status in Home Dialysis Patients: A Comparison of Modified Medical Research Council Dyspnea Scale, Physical Exam, and Point of Care Ultrasound (POCUS)",[],"2026-08-26T02:16:58.658552Z","2026-05-13T02:55:06.669018Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT05880537","Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry",[],"2026-08-26T02:15:04.877798Z","2026-05-13T02:55:06.390287Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT05717842","Simultaneous Prospective Kidney Transplant Assessment in Combined Liver Kidney Candidates",[],"2026-08-26T02:16:55.892527Z","2026-05-13T02:55:06.372832Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT06487546","Repletion of Ergothioneine in Patients With Kidney Failure",[],"2026-08-26T02:16:20.336282Z","2026-05-05T02:35:31.916085Z",{"nct_id":134,"title":135,"phases":136,"status":138,"updated_at":139,"content_modified":140},"NCT07583745","Study of EPN-701 for the Treatment of Calciphylaxis",[137],"Phase 2","NOT_YET_RECRUITING","2026-08-26T02:18:06.247899Z","2026-05-29T15:36:40.194351Z",{"nct_id":142,"title":143,"phases":144,"status":138,"updated_at":145,"content_modified":146},"NCT05725421","Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy",[],"2026-08-26T02:16:51.982021Z","2026-05-05T02:43:29.739139Z",{"nct_id":148,"title":149,"phases":150,"status":138,"updated_at":151,"content_modified":152},"NCT06649864","Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications",[82],"2026-08-26T02:15:58.452248Z","2026-05-05T02:43:29.511597Z",{"nct_id":154,"title":155,"phases":156,"status":138,"updated_at":157,"content_modified":158},"NCT07696962","Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease",[82],"2026-08-26T02:18:19.586423Z","2026-07-19T19:36:05.078420Z",{"nct_id":160,"title":161,"phases":162,"status":138,"updated_at":163,"content_modified":164},"NCT07645599","Microvasculature Ultrasound Super-resolution in Transplant Delayed Graft Function",[],"2026-08-26T02:17:05.172421Z","2026-06-14T18:39:22.264652Z",{"nct_id":166,"title":167,"phases":168,"status":138,"updated_at":169,"content_modified":170},"NCT07708038","Anti-Interleukin-6 (IL6) in Calciphylaxis",[82],"2026-08-26T02:16:33.772093Z","2026-07-19T19:36:05.091392Z",{"nct_id":172,"title":173,"phases":174,"status":138,"updated_at":175,"content_modified":176},"NCT07072767","Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation",[],"2026-08-26T02:15:42.447052Z","2026-05-05T02:43:28.558963Z",{"nct_id":178,"title":179,"phases":180,"status":181,"updated_at":182,"content_modified":183},"NCT06126380","Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients",[137],"ENROLLING_BY_INVITATION","2026-08-26T02:18:07.037408Z","2026-06-16T05:54:08.098958Z",{"nct_id":185,"title":186,"phases":187,"status":181,"updated_at":188,"content_modified":189},"NCT07428395","Feasibility of Intradialytic Monitoring During CKRT",[],"2026-08-26T02:15:40.343619Z","2026-06-16T05:54:07.884098Z",{"nct_id":191,"title":192,"phases":193,"status":181,"updated_at":194,"content_modified":195},"NCT05001009","Goals of Care Conversations Study",[],"2026-08-26T02:17:59.904383Z","2026-06-16T05:54:07.974561Z",{"nct_id":197,"title":198,"phases":199,"status":181,"updated_at":200,"content_modified":201},"NCT06938542","Palliative Care Needs of Children With Rare Diseases and Their Families",[],"2026-08-26T02:18:08.005333Z","2026-06-16T05:54:07.844998Z",[203],{"biomarker":204,"count":205,"slug":206},"X-linked Lymphoproliferative Syndrome 1",4,"x-linked-lymphoproliferative-syndrome-1",[208,212,216,219,223,227,230,234,237,240,243,246,249,252,255,258,262,265,268],{"state":209,"count":210,"slug":211},"California",11,"california",{"state":213,"count":214,"slug":215},"Massachusetts",10,"massachusetts",{"state":217,"count":214,"slug":218},"New York","new-york",{"state":220,"count":221,"slug":222},"Florida",8,"florida",{"state":224,"count":225,"slug":226},"Georgia",6,"georgia",{"state":228,"count":225,"slug":229},"Pennsylvania","pennsylvania",{"state":231,"count":232,"slug":233},"Michigan",5,"michigan",{"state":235,"count":232,"slug":236},"Minnesota","minnesota",{"state":238,"count":232,"slug":239},"North Carolina","north-carolina",{"state":241,"count":232,"slug":242},"Texas","texas",{"state":244,"count":205,"slug":245},"Illinois","illinois",{"state":247,"count":205,"slug":248},"Missouri","missouri",{"state":250,"count":205,"slug":251},"Nebraska","nebraska",{"state":253,"count":205,"slug":254},"Tennessee","tennessee",{"state":256,"count":205,"slug":257},"Virginia","virginia",{"state":259,"count":260,"slug":261},"Maryland",3,"maryland",{"state":263,"count":260,"slug":264},"Mississippi","mississippi",{"state":266,"count":260,"slug":267},"New Mexico","new-mexico",{"state":269,"count":260,"slug":270},"Ohio","ohio"]